ACE and coronary artery disorder: When perindopril as a new ACE inhibitor drug was introduced among patients with stable coronary heart disease it was showed in the EUROPA study that perindopril treatment can significantly improve outcome, namely it results in a 20% additional risk reduction (Fox and EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators, 2003).